Stay updated on Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.

Latest updates to the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page
- Check3 days agoChange DetectedThe page shows a new revision tag (v3.5.4) replacing the prior version, signaling a minor site update without altering study information.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page’s revision/version indicator at the bottom was updated from v3.5.2 to v3.5.3, reflecting an incremental update to the site itself rather than the underlying clinical trial information.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible changes to study details or page layout are indicated.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision: v3.5.0 replaced v3.4.3 in the page header/footer. No observed changes to the study details, eligibility criteria, or navigation.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check96 days agoChange DetectedThe page now shows Revision: v3.4.2, replacing Revision: v3.4.1. This is a minor UI/content label update that does not affect study information or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Cancer of Unknown Primary Clinical Trial page.